• June 3-6, 2024
  • San Diego Convention Center, California

Sessions

Loading

Creative Structures for Keeping Innovation Alive After the Deal

Monday, June 03, 2024
Breakout Session
Business Development and Finance
29AB
Life sciences transactions often focus on innovation and keeping that innovation alive is critical to ongoing success. In this panel, panelists will explore several different M&A and licensing models for keeping the innovation engine going including: acquired companies operating independently; option deals that maintain autonomy up to a certain development phase; milestone payments and contingent value rights; and employee retention plans. The session will engage our esteemed panelists from the pharma and biotech sectors, on their and their companies’ experiences and lessons learned, including a discussion on the M&A and licensing tactics that have been most successful.
Moderator
Oren Livne, JD, MBA
Partner
Baker McKenzie
Speakers
Gavin Liu, JD
Senior Director, Legal Strategic Transactions
Astellas
Paul van der Horst, PhD
Chief Business Officer
AgomAb Therapeutics
Deepa Talpade
Vice President, Head BD&L and Alliance Mgmt., Oncology
Bayer
Back to Session List

BIO DOUBLE HELIX SPONSORS

Thanks to our sponsors for supporting our mission to drive a revolution to cure patients, protect our climate, and nourish humanity.

Loading

BIO HELIX SPONSORS